Chemokine Therapy in Cats With Experimental Renal Fibrosis and in a Kidney Disease Pilot Study

Background: Chronic tubulointerstitial fibrosis is a common final pathway leading to end stage kidney disease in cats and has no effective treatment. The use of cell-based molecules to treat kidney fibrosis may be a promising approach. The objectives were to test the effects of intra-renal chemokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennington, Julie, Lankford, Shannon, Magalhaes, Renata S., Shankle, Douglas, Fanning, Jason, Kartini, Cucu, Suparto, Irma, Kusumawardhani, Winda, Putra, M. ArRaniri, Mariya, Silmi, Badlani, Gopal, Williams, J. Koudy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Veterinary Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969654/
https://www.ncbi.nlm.nih.gov/pubmed/33748219
http://dx.doi.org/10.3389/fvets.2021.646087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969654/
https://www.ncbi.nlm.nih.gov/pubmed/33748219
http://dx.doi.org/10.3389/fvets.2021.646087

Ejemplares similares